Despite its higher price, the results were worth it
Studies have examined the relationship between endometriosis and various markers of oxidative stress, including ROS, products of oxidation, detoxification enzymes, and antioxidants
[17] The status has since remained unsettled rather than resolved in the compounds favor: in 2026 the nomination behind that listing was withdrawn and BPC-157 was removed from Category 2, yet the FDA did not move it to the permitted (Category 1) list, and at its July 2026 Pharmacy Compounding Advisory Committee review the agency proposed against adding BPC-157 to the 503A bulk-substances list at all
Wally, O
As of now, the consensus among experts is that more research is needed particularly well-controlled human studies before we can fully endorse BPC-157s use in medicine
Drach J, Mahadevia R, Andreeff M